Few stocks have rewarded believers like Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) over the past 12 months. The shares have climbed 356.85% in a year, and the company just posted its first ever $200 million revenue quarter. The question now is whether the price has gotten ahead of the fundamentals.
The stock trades at $122.39. Our 24/7 Wall St. price target for Rocket Lab is $113.26, implying roughly 7.46% downside over the next 12 months. The recommendation is hold, with moderate confidence of 50%.
24/7 Wall St. Price Target Summary
| Metric | Value |
|---|---|
| Current Price | $122.39 |
| 24/7 Wall St. Price Target | $113.26 |
| Upside/Downside | -7.46% |
| Recommendation | HOLD |
| Confidence Level | 50% |
Why We Could Be Wrong
Our target sits below where Rocket Lab trades today. RKLB is one of the most divisive names in the market, and real upside could come from a successful Neutron debut later in 2026 or accelerating awards under the $17.9 billion Golden Dome program. Treat the target as one datapoint among many.
From $26 to $122: A 12-Month Reset
RKLB is up 75.44% year to date and 55.3% in the past month, though shares cooled 9.85% over the past week. The stock sits 31% off its 52-week high of $151.
Q1 fiscal 2026 results reported May 7 drove the move: revenue of $200.35 million beat the $189.41 million consensus by 5.77%, EPS of -$0.07 beat by 11.05%, and backlog hit a record $2.2 billion, up 20.2% sequentially. Management confirmed selection for the Department of War Space Based Interceptor program with Raytheon.
The Case for $150 and Higher
Bulls have a clean story. Q2 guidance calls for $225 million to $240 million in revenue, and the company signed 31 Electron/HASTE contracts plus 5 Neutron missions in a single quarter. CEO Peter Beck told investors “Of all of the things that I sit awake at night worrying about, Neutron demand is just not one of them.”
A successful Neutron debut would crack open medium-lift national security launch, currently dominated by SpaceX and ULA. Our bull case scenario points to $150.56 by June 2027, a 23.02% gain. Of 17 covering analysts, 12 carry Buy or Strong Buy ratings with zero sells.
What Could Go Wrong
The bear case starts with valuation. Rocket Lab carries a market cap near $70.85 billion against FY2025 revenue of $601.8 million and a net loss of $198.2 million. Stock-based compensation ran $28.1 million in Q1, and the company raised $450.4 million via an ATM offering.
Bulls counter that dilution funded $2 billion in liquidity for Neutron and M&A, and heavy spend funds long-term scale. The bear case scenario points to $86.10 by June 2027, a 29.65% drawdown.
Rocket Lab Price Prediction 2026-2030
My 24/7 Wall St. price target for Rocket Lab is $113.26 with a hold rating and 50% confidence. The gap between fundamentals and price after a 356.85% run tips the scale.
A clean Q4 2026 Neutron debut and sizable Golden Dome awards would strengthen the bull case, while a Neutron slip into 2027 or continued SBC and dilution would reinforce the bear case. For longs sitting on gains, the setup warrants close monitoring.
Looking further ahead, here is where our model projects Rocket Lab could trade, assuming current growth trajectories and market conditions hold.
| Year | 24/7 Wall St. Price Target |
|---|---|
| 2026 | $113 |
| 2027 | $114 |
| 2028 | $115 |
| 2029 | $116 |
| 2030 | $117 |
These projections assume Rocket Lab executes on its current strategy. Significant upside could come from a Neutron production ramp and Golden Dome contracts, while downside risk persists from execution slippage and continued GAAP losses.
Top Gaining Stocks
Top Losing Stocks